Drinking regular and decaffeinated coffee is linked to lower risks of cirrhosis, liver cancer, and liver-related death, according to a new study.
These findings suggest that a common daily habit could serve as a protective factor against some of the most severe forms of liver failure. Because the results apply to both caffeinated and decaffeinated varieties, the benefit may be tied to compounds other than caffeine.
The research involved more than 350,000 people [1]. Experts said, "A new study of more than 350,000 people suggests coffee, regular and decaf, may protect against serious liver ailments" [1].
According to the data, the consumption of coffee is associated with a reduced risk of developing cirrhosis, liver cancer, and liver-related death [1]. The study was published July 3, 2026 [2].
Researchers said that drinking coffee — even decaf — is linked to these improved health outcomes [2]. While the correlation is strong, the exact biological mechanisms that provide this protection are not yet fully understood [2].
The large sample size of the study allows the findings to be applicable globally [3]. This suggests that the protective effects of coffee are consistent across different populations and demographics [3].
“Drinking coffee — even decaf — is linked to lower risks of cirrhosis, liver cancer, and liver-related death”
This study adds to a growing body of evidence suggesting that coffee contains polyphenols or other antioxidants that support liver function. By demonstrating that decaf coffee provides similar benefits to regular coffee, the research indicates that the protective properties are likely inherent to the coffee bean itself rather than the stimulant effects of caffeine.
